skip to content
Countering the problem of falsified and substandard drugs Preview this item
ClosePreview this item
Checking...

Countering the problem of falsified and substandard drugs

Author: Gillian J Buckley; Lawrence O Gostin; Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products,
Publisher: Washington, D.C. : National Academies Press, 2013.
Edition/Format:   Print book : EnglishView all editions and formats
Summary:
"The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter,  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: Online version:
Countering the problem of falsified and substandard drugs.
Washington : National Academies Press, 2013
(OCoLC)839275199
Material Type: Internet resource
Document Type: Book, Internet Resource
All Authors / Contributors: Gillian J Buckley; Lawrence O Gostin; Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products,
ISBN: 9780309269391 0309269393
OCLC Number: 850372447
Description: xxiv, 351 pages : illustrations, portrait ; 24 cm
Contents: The effects of falsified and substandard drugs --
The magnitude of the problem --
Causes of falsified and substandard drugs --
Weaknesses in the drug distribution chain --
Detection technology --
An international code of practice for falsified and substandard medicines.
Responsibility: Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies.

Abstract:

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. This title accepts the narrow meaning of counterfeit, and, because the  Read more...

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/850372447> # Countering the problem of falsified and substandard drugs
    a schema:Book, schema:CreativeWork ;
   library:oclcnum "850372447" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/droit_international> ; # Droit international
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/contrefacons> ; # Contrefaçons
   schema:about <http://id.loc.gov/authorities/subjects/sh2008109170> ; # Pharmaceutical industry--Quality control
   schema:about <http://id.worldcat.org/fast/1060129> ; # Pharmaceutical industry
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/counterfeit_drugs> ; # Counterfeit Drugs
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/pharmaceutical_preparations_standards> ; # Pharmaceutical Preparations--standards
   schema:about <http://dewey.info/class/338.476151/e23/> ;
   schema:about <http://id.worldcat.org/fast/1060169> ; # Pharmaceutical industry--Quality control
   schema:about <http://id.loc.gov/authorities/subjects/sh2008104076> ; # Fraud--Prevention
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/international_cooperation> ; # International Cooperation
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/quality_control> ; # Quality Control
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/drug_contamination_prevention_&_control> ; # Drug Contamination--prevention & control
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/medecins> ; # Médecins
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/fraud_prevention_&_control> ; # Fraud--prevention & control
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/organisation_mondiale_de_la_sante> ; # Organisation mondiale de la santé
   schema:about <http://id.worldcat.org/fast/933790> ; # Fraud--Prevention
   schema:about <http://experiment.worldcat.org/entity/work/data/1362822365#Topic/produits_pharmaceutiques> ; # Produits pharmaceutiques
   schema:author <http://viaf.org/viaf/306313854> ; # Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products,
   schema:bookFormat bgn:PrintBook ;
   schema:datePublished "2013" ;
   schema:description ""The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines"--Publisher's description."@en ;
   schema:description "The effects of falsified and substandard drugs -- The magnitude of the problem -- Causes of falsified and substandard drugs -- Weaknesses in the drug distribution chain -- Detection technology -- An international code of practice for falsified and substandard medicines."@en ;
   schema:editor <http://viaf.org/viaf/306313580> ; # Gillian J. Buckley
   schema:editor <http://viaf.org/viaf/36952649> ; # Lawrence Ogalthorpe Gostin
   schema:exampleOfWork <http://worldcat.org/entity/work/id/1362822365> ;
   schema:inLanguage "en" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/839275199> ;
   schema:name "Countering the problem of falsified and substandard drugs"@en ;
   schema:productID "850372447" ;
   schema:url <http://www.ncbi.nlm.nih.gov/books/NBK202530/> ;
   schema:url <http://www.nap.edu/catalog.php?record_id=18272> ;
   schema:workExample <http://worldcat.org/isbn/9780309269391> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/850372447> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/1362822365#Topic/droit_international> # Droit international
    a schema:Intangible ;
   schema:name "Droit international"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1362822365#Topic/drug_contamination_prevention_&_control> # Drug Contamination--prevention & control
    a schema:Intangible ;
   schema:name "Drug Contamination--prevention & control"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1362822365#Topic/fraud_prevention_&_control> # Fraud--prevention & control
    a schema:Intangible ;
   schema:name "Fraud--prevention & control"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1362822365#Topic/international_cooperation> # International Cooperation
    a schema:Intangible ;
   schema:name "International Cooperation"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1362822365#Topic/organisation_mondiale_de_la_sante> # Organisation mondiale de la santé
    a schema:Intangible ;
   schema:name "Organisation mondiale de la santé"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1362822365#Topic/pharmaceutical_preparations_standards> # Pharmaceutical Preparations--standards
    a schema:Intangible ;
   schema:name "Pharmaceutical Preparations--standards"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/1362822365#Topic/produits_pharmaceutiques> # Produits pharmaceutiques
    a schema:Intangible ;
   schema:name "Produits pharmaceutiques"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2008104076> # Fraud--Prevention
    a schema:Intangible ;
   schema:name "Fraud--Prevention"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2008109170> # Pharmaceutical industry--Quality control
    a schema:Intangible ;
   schema:name "Pharmaceutical industry--Quality control"@en ;
    .

<http://id.worldcat.org/fast/1060129> # Pharmaceutical industry
    a schema:Intangible ;
   schema:name "Pharmaceutical industry"@en ;
    .

<http://id.worldcat.org/fast/1060169> # Pharmaceutical industry--Quality control
    a schema:Intangible ;
   schema:name "Pharmaceutical industry--Quality control"@en ;
    .

<http://id.worldcat.org/fast/933790> # Fraud--Prevention
    a schema:Intangible ;
   schema:name "Fraud--Prevention"@en ;
    .

<http://viaf.org/viaf/306313580> # Gillian J. Buckley
    a schema:Person ;
   schema:familyName "Buckley" ;
   schema:givenName "Gillian J." ;
   schema:name "Gillian J. Buckley" ;
    .

<http://viaf.org/viaf/306313854> # Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products,
    a schema:Organization ;
   schema:name "Institute of Medicine (U.S.). Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products," ;
    .

<http://viaf.org/viaf/36952649> # Lawrence Ogalthorpe Gostin
    a schema:Person ;
   schema:familyName "Gostin" ;
   schema:givenName "Lawrence Ogalthorpe" ;
   schema:givenName "Lawrence O." ;
   schema:name "Lawrence Ogalthorpe Gostin" ;
    .

<http://worldcat.org/isbn/9780309269391>
    a schema:ProductModel ;
   schema:isbn "0309269393" ;
   schema:isbn "9780309269391" ;
    .

<http://www.worldcat.org/oclc/839275199>
    a schema:CreativeWork ;
   rdfs:label "Countering the problem of falsified and substandard drugs." ;
   schema:description "Online version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/850372447> ; # Countering the problem of falsified and substandard drugs
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.